The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)

NCT02500680 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: MER4101
BIOLOGICAL: Inactivated Influenza Vaccine

Sponsor

Nova Immunotherapeutics Limited

Collaborators

[object Object]
[object Object]
[object Object]